Answers are grounded in this paper and cite their sources.
Metabolic Bone Disease (MBD) is a clinical sign of a disease called Nutritional Secondary Hyperparathyroidism (NSHP). This is when there is not enough calcium in the diet and incorrect/insufficient UVB provision, or the calcium:phosphorus (Ca:P) ratio becomes imbalanced, causing the calcium levels in the blood to decrease resulting in hypocalcaemia (low blood calcium). This decrease is detected by the kidneys and the parathyroid gland is alerted to produce parathormone to rebalance the blood calcium levels by removing calcium from the bones to increase the level in the bloodstream.
No takes yet. Share an insight, caveat, or question.
G Bell (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: